Open Innovation

Open Innovation That Supports Drug Discovery

ONO has discovered new drug discovery seeds and developed breakthrough new drugs initiated through collaboration with research institutes including universities since before the words “open innovation” started to become widely used. With Discovery Research Alliance and Corporate Development & Strategy Business Development taking the lead, we continue to pursue drug discovery collaborations and vigorous compound licensing activities with world top-class researchers and biopharmaceutical companies mainly in the priority areas of research. We also pursue collaboration activities with speed to collect cutting-edge scientific information and proceed with drug discovery based thereon ahead of the competition as fast as possible. We post employees with extensive experience in discovery research to our overseas subsidiaries in the US and UK, and they visit world top-class researchers and biopharmaceutical companies in the US and Europe to launch alliances.
Through the Ono Pharma Foundation, which was established in 2017, we provide grants for research activities in academia with an eye toward the future. We select research grant winners every year and subsidize attractive basic research projects that may bring about innovations in the future. This has led even to grant winners developing a social network in the field of frontier sciences.
To strengthen and accelerate these activities to realize a more strategically wide range of open innovation, we established a subsidiary in the US named Ono Venture Investment, Inc. This company manages Ono Venture Investment Fund I, L.P. (established in July 2020), a venture capital fund in the US, and make investments focused on early stage biopharma startups for the purpose of strategic investment in drug targets and cutting-edge technologies to discover innovative drugs. By adding to open innovation the new framework of capital alliances with and investments in biopharmaceutical companies,we strive to be more competitive in drug discovery and R&D.

ONO PHARMA FOUNDATION has research grant programs for prospective researchers who may bring about innovations in the future.

Ono Venture Investment invests in early stage biopharma startups for the purpose of drug target identification and in-licensing or partnering of cutting-edge technologies to discover innovative drugs.